In Brief: Chiron Chinese venture
This article was originally published in The Gray Sheet
Executive Summary
Chiron Chinese venture: Chiron Diagnostics announces agreement with Shanghai Long-March Trace Medical Science Co. for the manufacture and distribution of its critical care and routine chemistry reagents in China. Chiron will acquire 22% of its distribution partner, which will change its name to Shanghai Long-March Chiron Medical Science...